Daiichi Sankyo starts selling stake in Sun Pharma: Report

21 Apr 2015 Evaluate

Daiichi Sankyo has reportedly started the sale of the Sun Pharmaceutical’s stake, worth up to $3.6 billion, through accelerated book building. Daiichi Sankyo is selling the said stake at price lower than market level.

After the sale, Daiichi Sankyo will not be a major shareholder of Sun Pharma. As of April 16, 2015, Daiichi owned 21.49 crore shares of Sun Pharma.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1610.15 -29.15 (-1.78%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×